Advertisement

Nephrology

Resource Center

Featured

Review
Review
05/31/2023
Incidental adrenal tumors are common but are most often asymptomatic. The challenge for primary care providers is to determine the hormone secretion status and malignancy potential. This article outlines...
05/31/2023
Case in Point
Case in Point
05/18/2023

Geethika Thota, MD1Mehak Bassi, MD2 • Niraj Ballam Nagaraj, MD3

Geethika Thota, MD1• Mehak Bassi, MD2 • Niraj Ballam Nagaraj, MD3
A 39-year-old woman with no significant medical history presented to the emergency department reporting low back pain, nausea, and vomiting for 1 day.
05/18/2023
Podcast
James Matera, DO
Podcast
Advertisement

Interactive Features

Pop Quiz
blood sample
Pop Quiz
Legal Pearl
Legal Pearl
02/16/2023
A 63-year-old man with hepatitis C, cirrhosis of the liver, end-stage liver disease, renal failure, and congestive heart failure, was brought to the hospital by ambulance for complaints of weakness in his...
02/16/2023
lupus
lupus
09/04/2022
Lupus nephritis can lead to endstage kidney disease, with catastrophic progression to ESKD within several years of onset relatively uncommon. What factors are associated with the risk of catastrophic...
09/04/2022
Health Outcomes
Health Outcomes
03/27/2022
If a patient presents with a GFR category G3a and a persistent albuminuria category of A2, to which risk category does he or she belong? Test your knowledge with our latest pop quiz!
03/27/2022
Pop Quiz
Pop Quiz
11/02/2021
In FIGARO-DKD, the primary outcome measure is a composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Of these outcomes, do...
11/02/2021

Clinical Insights

Podcast
James Matera, DO
Podcast
Expert Q&A
Expert Q&A
05/10/2023
In this Q&A, Ping Liu, PhD, and Pietro Ravani, MD, PhD, answer our questions about the diagnosis and management of chronic kidney disease (CKD) and discuss how the current definition of CKD does not...
05/10/2023
Video
Video
05/02/2023
In this video, Eric Gottlieb, MD, MS, discusses the use of cystatin C vs creatinine to estimate glomerular filtration rate in diverse patient populations and how the use of cystatin C to estimate GFR can...
05/02/2023
Multidisciplinary Dialogue: Clinical Rounds and Case Reviews, Ep. 4
Multidisciplinary Dialogue
Multidisciplinary Dialogue: Clinical Rounds and Case Reviews, Ep. 4
Expert Q&A
Expert Q&A
04/10/2023
In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
04/10/2023